Anti- Vancomycin polyclonal antibody

Aims This study aimed to investigate the antimicrobial resistance (AMR) profiles and genotypes ofStreptococcus suisfrom Jiangxi Province, China. Methods and Results A total of 314 nasal swab samples were collected from clinically healthy pigs, with a positive isolation rate ofS. suisof 34 center dot 08%. Antimicrobial susceptibility testing showed that more than 80% of the isolates were susceptible to vancomycin, penicillin, minocycline and chloramphenicol. A high frequency of resistance to clindamycin, tetracycline, clarithromycin and erythromycin was observed. All of the isolates were resistant to three or more categories of antimicrobials. Theerm(B) andtet(O) served as the most frequent genotypes that contributed to lincosamide, macrolide and tetracycline resistances. A part of macrolide-resistant genotypes could not exhibit specific phenotypes. Finally, integrative and conjugative elements (ICEs) were identified in 28 center dot 97% of the isolates. Conclusions The multidrug resistance ofS. suishas widely emerged in Jiangxi Province. The most prevalent resistance genes and genotypes were similar to those in other regions or countries. The presence of ICEs is increasing the risk of horizontal transfer of AMR genes. Significance and Impact of the Study The findings could provide guidance for the rational use of antimicrobial drugs and be helpful for monitoring the AMR information ofS. suisin China.

A rapid and simple ultra high performance liquid chromatography with tandem mass spectrometry method was developed and validated for the simultaneous separation and determination of vancomycin and its crystalline degradation products in human serum. Vancomycin and two isomers of the degradants were extracted from human serum with a protein precipitation method. The compounds were separated on an Acquity BEH C18 column (2.1 x 50 mm, 1.7 mu m) eluted with a gradient mixture of acetonitrile and 0.1% formic acid as the mobile phase. Norvancomycin was used as the internal standard. The linear ranges of vancomycin and two degradant isomers were 1.057-105.7, 0.1437-14.37, and 0.2540-25.40 mu g/mL, respectively. The established methods were validated and successfully applied to a therapeutic drug monitoring study of vancomycin in patients with renal insufficiency.